UY36162A - COMPLEJO DE POLIPROTEÍNAS INMUNOGÉNICAS DE M. hyopneumoniae y GEN SINTÉTICO CODIFICANTE DEL COMPLEJO DE POLIPROTEÍNAS INMUNOGÉNICAS DE M. hyopneumoniae - Google Patents

COMPLEJO DE POLIPROTEÍNAS INMUNOGÉNICAS DE M. hyopneumoniae y GEN SINTÉTICO CODIFICANTE DEL COMPLEJO DE POLIPROTEÍNAS INMUNOGÉNICAS DE M. hyopneumoniae

Info

Publication number
UY36162A
UY36162A UY0001036162A UY36162A UY36162A UY 36162 A UY36162 A UY 36162A UY 0001036162 A UY0001036162 A UY 0001036162A UY 36162 A UY36162 A UY 36162A UY 36162 A UY36162 A UY 36162A
Authority
UY
Uruguay
Prior art keywords
complex
hyopneumoniae
immunogenic
polyprotein
polyprotein complex
Prior art date
Application number
UY0001036162A
Other languages
English (en)
Inventor
Celso Raul Romero Ramos
Miryam Marroquin Quelopana
Original Assignee
Ouro Fino Saúde Animal Ltda
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ouro Fino Saúde Animal Ltda filed Critical Ouro Fino Saúde Animal Ltda
Publication of UY36162A publication Critical patent/UY36162A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0241—Mollicutes, e.g. Mycoplasma, Erysipelothrix
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/116—Polyvalent bacterial antigens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/30—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Mycoplasmatales, e.g. Pleuropneumonia-like organisms [PPLO]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55561—CpG containing adjuvants; Oligonucleotide containing adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55577—Saponins; Quil A; QS21; ISCOMS
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • A61K2039/575—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 humoral response
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6068—Other bacterial proteins, e.g. OMP
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)

Abstract

?Complejo de poliproteínas conteniendo regiones inmunogénicas derivadas de los antígenos P36, P46, HSP, NrdF, P97, MHP271 y P216 de M. hyopneumoniae, fusionados con segmentos de las proteínas portadoras Rrp4, Rrp41 y Rrp42 de P. abyssi, formando un complejo único, y adicionalmente proporcionar: (i) un gen codificante del complejo de poliproteínas, dicho complejo basado en el exosoma de P. abyssi llevando copias de antígenos vacunales de M. hyopneumoniae; (ii) una composición antigénica comprendiendo el complejo de poliproteínas de la Invención; (iii) un proceso de obtención de dicho complejo de poliproteína."
UY0001036162A 2014-06-16 2015-06-10 COMPLEJO DE POLIPROTEÍNAS INMUNOGÉNICAS DE M. hyopneumoniae y GEN SINTÉTICO CODIFICANTE DEL COMPLEJO DE POLIPROTEÍNAS INMUNOGÉNICAS DE M. hyopneumoniae UY36162A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BR102014014727-6A BR102014014727B1 (pt) 2014-06-16 2014-06-16 COMPLEXO DE POLIPROTEÍNAS IMUNOGÊNICAS DE M. hyopneumoniae, GENE SINTÉTICO CODIFICANTE DO COMPLEXO DE POLIPROTEÍNAS IMUNOGÊNICAS DE M. hyopneumoniae, COMPOSIÇÃO ANTIGÊNICA, PROCESSO DE OBTENÇÃO DE UM COMPLEXO DE POLIPROTEÍNAS IMUNOGÊNICAS DE M. hyopneumoniae

Publications (1)

Publication Number Publication Date
UY36162A true UY36162A (es) 2016-01-08

Family

ID=54934584

Family Applications (1)

Application Number Title Priority Date Filing Date
UY0001036162A UY36162A (es) 2014-06-16 2015-06-10 COMPLEJO DE POLIPROTEÍNAS INMUNOGÉNICAS DE M. hyopneumoniae y GEN SINTÉTICO CODIFICANTE DEL COMPLEJO DE POLIPROTEÍNAS INMUNOGÉNICAS DE M. hyopneumoniae

Country Status (6)

Country Link
US (1) US20170274062A1 (es)
EP (1) EP3175864A4 (es)
AR (1) AR100824A1 (es)
BR (1) BR102014014727B1 (es)
UY (1) UY36162A (es)
WO (1) WO2015192196A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017175253A1 (ja) * 2016-04-04 2017-10-12 国立研究開発法人医薬基盤・健康・栄養研究所 エキソソーム標的ｄｎａワクチン
CN109055412B (zh) * 2018-08-08 2022-07-12 武汉科前生物股份有限公司 一种猪圆环病毒-肺炎支原体二联亚单位疫苗及其制备方法
CN112891524A (zh) * 2020-12-09 2021-06-04 扬州优邦生物药品有限公司 猪肺炎支原体病亚单位疫苗组合物及其制备方法和应用
CN113092783A (zh) * 2021-04-06 2021-07-09 中农华大(武汉)检测科技有限公司 一种猪肺炎支原体抗体检测方法及应用
CN113588946B (zh) * 2021-07-26 2022-06-10 山东省滨州畜牧兽医研究院 一种猪肺炎支原体抗体间接elisa检测用的重组蛋白和方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPN178995A0 (en) * 1995-03-16 1995-04-13 University Of Melbourne, The Antigen composition
AUPP727398A0 (en) * 1998-11-20 1998-12-17 Commonwealth Scientific And Industrial Research Organisation Methods of identifying antigen gene sequences
CA2340455A1 (en) * 2001-03-28 2002-09-28 Pfizer Products Inc. Nucleic acids and proteins of the mycoplasma hyopneumoniae mhp3 gene and uses thereof
DK2027873T3 (en) * 2001-07-02 2015-11-09 Zoetis Services Llc Single Dose Vaccination with Mycoplasma hyopneumoniae
JP2006311824A (ja) * 2005-05-09 2006-11-16 National Agriculture & Food Research Organization 豚マイコプラズマ肺炎ワクチン
US9120859B2 (en) * 2012-04-04 2015-09-01 Zoetis Services Llc Mycoplasma hyopneumoniae vaccine
CA2776119C (en) * 2012-04-27 2018-12-11 Transfert Plus, Societe En Commandite Mycoplasma hyponeumoniae p97 adhesin protein and uses thereof as vaccine adjuvant
BR102014014502B1 (pt) * 2014-06-13 2020-09-15 Ouro Fino Saúde Animal Ltda Vetor de expressão

Also Published As

Publication number Publication date
AR100824A1 (es) 2016-11-02
EP3175864A1 (en) 2017-06-07
WO2015192196A1 (pt) 2015-12-23
US20170274062A1 (en) 2017-09-28
BR102014014727B1 (pt) 2018-04-03
BR102014014727A2 (pt) 2016-03-15
EP3175864A4 (en) 2018-01-03

Similar Documents

Publication Publication Date Title
CY1121539T1 (el) Ειδικοι για κλαυδiνη-6 ανοσοϋποδοχεις και επιτοποι τ-κυτταρων
CO2018011804A2 (es) Receptores quiméricos de flt3 y métodos de uso de los mismos
CY1124106T1 (el) Συνθεσεις μεταφορεα-αντισωματος και μεθοδοι παρασκευης και χρησης αυτων
CO2017005639A2 (es) Anticuerpos anti-miostatina, polipéptidos que contienen regiones fc variantes
CY1124806T1 (el) Αντισωματα enanti-cd40 και χρησεις αυτων
CY1123598T1 (el) Μακροκυκλικα πεπτιδια χρησιμα ως ανοσοδιαμορφωτες
CY1124254T1 (el) Μεθοδοι και συνθεσεις για την προκληση προστατευτικης ανοσιας εναντι λοιμωξης ιου της ανθρωπινης ανοσοανεπαρκειας
UY37278A (es) Anticuerpos anti-b7-h3 y conjugados de fármaco y anticuerpos
CY1122035T1 (el) Αντισωματα μονης περιοχης που κατευθυνονται εναντι ενδοκυτταρικων αντιγονων
UY36162A (es) COMPLEJO DE POLIPROTEÍNAS INMUNOGÉNICAS DE M. hyopneumoniae y GEN SINTÉTICO CODIFICANTE DEL COMPLEJO DE POLIPROTEÍNAS INMUNOGÉNICAS DE M. hyopneumoniae
BR112019012343A2 (pt) anticorpos il-11ra
CY1124979T1 (el) Κατασκευασματα πρωτεϊνης uspa2 και χρησεις αυτων
CO2019010503A2 (es) Plataforma de identificación de péptidos inmunogénicos personalizada
CL2017003240A1 (es) Anticuerpos anti-rnf43 novedosos y métodos para su uso
CY1122705T1 (el) Αντιγονα, διαβιβαστες, συνθεσεις του ιου της ανθρωπινης ανοσοανεπαρκειας,και μεθοδοι χρησης τους
UY37523A (es) Anticuerpos anti-ox40 y sus usos
BR112019012342A2 (pt) anticorpos il-11
BR112017017293A2 (pt) método para predizer modificações de aminoácidos, para selecionar e/ou classificar modificações de aminoácidos e para fornecer uma vacina e vacina
CL2018001722A1 (es) Nuevos anticuerpos anti-mfi2 y métodos de uso (divisional solicitud 201700506)
CY1123520T1 (el) Μεθοδοι για την προβλεψη της χρησιμοτητας των νεων αντιγονων για ανοσοθεραπεια
MX2018015277A (es) Anticuerpos anti-b7-h3 y conjugados de anticuerpo y farmaco.
MX2018015285A (es) Anticuerpos anti-b7-h3 y conjugados de anticuerpo y farmaco.
IN2014CH00396A (es)
BR112017013568A2 (pt) compostos bicíclicos fundidos para o tratamento de doenças
EA201790239A1 (ru) Молекула-носитель для антигенов

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20220620